Кудайбергенова А. Г.¹, Туркевич Е. А.¹, Горбань Н. А.²

¹ФГБУ «Научно-исследовательский институт онкологии им. Н. Н. Петрова» Минздрава России; Россия, 197758 Санкт-Петербург, п. Песочный, ул. Ленинградская, 68;

²ФГБУ «Центральная клиническая больница с поликлиникой» Управления делами Президента Российской Федерации; Россия, 121359 Москва, ул. Маршала Тимошенко, 15

1. WHO Classification of Tumours Editorial Board. Soft tissue and bone tumours. Lyon (France). International Agency for Research on Cancer, 2020. (WHO classification of tumours series, 5th ed., vol. 3). URL: https://publications.iarc.fr/588

2. Mandelstamm M. Über primäre Neubildungen des Herzens. Virchows Arch 1923;245:43–54. DOI: https://doi.org/10.1007/BF01992097

3. Thomas-de-Montpre´ville V., Nottin R., Dulmet E. et al. Heart tumors in children and adults: clinicopathological study of 59 patients from a surgical center. Cardiovasc Pathol 2007;16(1): 22–8. DOI: https://doi.org/10.1016/j.carpath.2006.05.008

4. Kim C.H., Dance J.Y, Coffey D. et al. Clinicopathologic study of 24 patients with primary cardiac sarcomas: a 10-year single institutionexperience. Hum Pathol 2008;39:933–8. DOI: https://doi.org/10.1016/j.humpath.2007.12.018

5. Федоров С.А., Медведев А.П., Целоусова Л.М. и др. Интимальная саркома легочной артерии, протекающая под маской тромбоэмболии легочной артерии: результаты хирургического лечения. Комплексные проблемы сердечно-сосудистых забо- леваний 2023;12(2):196–206. DOI: https://doi.org/10.17802/2306-1278-2023-12-2-196-206 Fedorov S.A., Medvedev A.P., Tselousova L.M. et al. Pulmonary artery intimal sarcoma mimicking pulmonary embolism: surgical treatment results. Kompleksnye problemy serdechno-sosudistykh zabolevaniy = Complex Issues of Cardiovascular Diseases 2023;12(2):196–206. (In Russ.). DOI: https://doi.org/10.17802/2306-1278-2023-12-2-196-206

6. Simpson L., Kumar S.K., Okuno S.H. et al. Malignant primary cardiac tumors. Cancer 2008;112:2440–6. DOI: https://doi.org/10.1002/cncr.23459

7. Kumar N., Agarwal S., Ahuja A. et al. Spectrum of cardiac tumors excluding myxoma: experience of a tertiary center with review of the literature. Pathol Res Pract 2011;207:769–74. DOI: https://doi.org/10.1016/j.prp.2011.09.014

8. Zhang P.J., Brooks J.S., Goldblum J.R. et al. Primary cardiac sarcomas: a clinicopathologic analysis of a series with follow-up information in 17 patients and emphasis on long-term survival. Hum Pathol 2008;39:1385–95. DOI: https://doi.org/10.1016/j.humpath.2008.01.019

9. Neragi-Miandoab S., Kim J., Vlahakes G.J. Malignant tumours of the heart: a review of tumour type, diagnosis and therapy. Clin Oncol 2007;19(10):748–56. DOI: https://doi.org/10.1016/j.clon.2007.06.009

10. Burke A. Primary malignant cardiac tumors. Semin Diagn Pathol 2008;25(1):39–46. DOI: https://doi.org/10.1053/j.semdp.2007.10.006

11. Blackmon S.H., Patel A., Reardon M.J. Management of primary cardiac sarcomas. Expert Rev Cardiovasc Ther 2008;6:1217–22. DOI: https://doi.org/10.1586/14779072.6.9.1217

12. Neuville A., Collin F., Bruneval P. et al. Intimal sarcoma is the most frequent primary cardiac sarcoma: clinicopathologic and molecular retrospective analysis of 100 primary cardiac sarcomas. Am J Surg Pathol 2014;38(4):461–9. DOI: https://doi.org/10.1097/PAS.0000000000000184

13. Neuville A., Ranche`re-Vince D., Dei Tos A.P. et al. Impact of molecular analysis on the final sarcoma diagnosis: a study on 763 cases collected during a European epidemiological study. Am J Surg Pathol 2013;37:1259–68. DOI: https://doi.org/10.1097/PAS.0b013e31828f51b9

14. Bui Nguyen Binh M., Sastre-Garau X., Guillou L. et al. MDM2 and CDK4 immunostainings are useful adjuncts in diagnosing well-differentiated and dedifferentiated liposarcoma subtypes. A comparative analysis of 559 soft tissue neoplasms with genetic data. Am J Surg Pathol 2005; 29:1340–7. DOI: https://doi.org/10.1097/01.pas.0000170343.09562.39

15. Dewaele B., Floris G., Finalet-Ferreiro J. et al. Coactivated platelet-derived growth factor receptor α and epidermal growth factor receptor are potential therapeutic targets in intimal sarcoma. Cancer Res 2010;70:7304–14. DOI: https://doi.org/10.1158/0008-5472.CAN-10-1543

16. Boland J.M., Colby T.V., Folpe A.L. Liposarcomas of the mediastinum and thorax: a clinicopathologic and molecular cytogenetic study of 24 cases, emphasizing unusual and diverse histologic features. Am J Surg Pathol 2012;36:1395–403. DOI: https://doi.org/10.1097/PAS.0b013e3182562bc1

17. Coindre J.M., Pe´deutour F., Aurias A. Well-differentiated and dedifferentiated liposarcomas. Virchows Arch 2010;456:167–79. DOI: https://doi.org/10.1007/s00428-009-0815-x

18. Dujardin F., Binh M.B., Bouvier C. et al. MDM2 and CDK4 immunohistochemistry is a valuable tool in the differential diagnosis of low-grade osteosarcomas and other primary fibro-osseous lesions of the bone. Mod Pathol 2011;24:624–37. DOI: https://doi.org/10.1038/modpathol.2010.229

19. Coindre J.M., Pelmus M., Hostein I. et al. Should molecular testing be required for diagnosing synovial sarcoma? A prospective study of 204 cases. Cancer 2003;98:2700–7. DOI: https://doi.org/10.1002/cncr.11840